Citations (164)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (25)
I Hsien Li, Wen Ling Hsieh & Wen I Liu. (2023) A Systematic Review and Meta-Analysis of the Effectiveness of Adherence Therapy and Its Treatment Duration in Patients with Schizophrenia Spectrum Disorders. Patient Preference and Adherence 17, pages 769-780.
Read now
Read now
Stefano Bramante, Gabriele Di Salvo, Giuseppe Maina & Gianluca Rosso. (2023) Paliperidone Palmitate: A Breakthrough Treatment for Schizophrenia? A Review on Patient Adherence Levels, Healthcare Resource Utilization and Costs. Neuropsychiatric Disease and Treatment 19, pages 519-530.
Read now
Read now
Wen Ling Hsieh, Shin Ting Yeh, Wen I Liu, I Hsien Li, Shih Kai Lee & Wai Tong Chien. (2022) Improving Medication Adherence in Community-Dwelling Patients with Schizophrenia Through Therapeutic Alliance and Medication Attitude: A Serial Multiple Mediation Model. Patient Preference and Adherence 16, pages 1017-1026.
Read now
Read now
S Kor Spoelstra, Jojanneke Bruins, Leonie Bais, Paul Seerden, Stynke Castelein & Henderikus Knegtering. (2022) One-Month versus Three-Month Formulation of Paliperidone Palmitate Treatment in Psychotic Disorders: Patients’, Relatives’, and Mental Health Professionals’ Perspectives. Patient Preference and Adherence 16, pages 615-624.
Read now
Read now
Samer A. El Hayek, Malek A. Shatila, Jana A. Adnan, Luna E. Geagea, Firas Kobeissy & Farid R. Talih. (2022) Is there a therapeutic potential in combining bupropion and naltrexone in schizophrenia?. Expert Review of Neurotherapeutics 22:9, pages 737-749.
Read now
Read now
Maria Sacha, Hinuga Sandahl, Line Harck & Jessica Carlsson. (2022) Treatment adherence to psychotropic drugs among non-Western migrants: a systematic review. Nordic Journal of Psychiatry 76:4, pages 250-262.
Read now
Read now
Marzieh Asadi$suffix/text()$suffix/text(), Vahid Rashedi$suffix/text()$suffix/text(), Nooshin Khademoreza$suffix/text()$suffix/text(), Ruohollah Seddigh$suffix/text()$suffix/text(), Amir-Abbas Keshavarz-Akhlaghi$suffix/text()$suffix/text(), Hamidreza Ahmadkhaniha$suffix/text()$suffix/text(), Seied-Mohamadhosein Rezvaniardestani, Ali Lotfi & Mohammadreza Shalbafan$suffix/text()$suffix/text(). (2022) Medication Adherence and Drug Attitude Amongst Male Patients with the Methamphetamine-Induced Psychotic Disorder After Discharge: A Three Months Follow Up Study. Journal of Psychoactive Drugs 54:1, pages 18-24.
Read now
Read now
Kari Standal, Ole Andre Solbakken, Jorun Rugkåsa, Astrid Ringen Martinsen, Margrethe Seeger Halvorsen, Allan Abbass & Kristin Sverdvik Heiervang. (2021) Why Service Users Choose Medication-Free Psychiatric Treatment: A Mixed-Method Study of User Accounts. Patient Preference and Adherence 15, pages 1647-1660.
Read now
Read now
Carolyn Martin, Eleena Koep, John White, Angela Belland, Heidi Waters & Felicia Forma. (2021) Treatment Compliance Communications Between Patients with Severe Mental Illness and Treating Healthcare Providers: A Retrospective Study of Documentation Using Healthcare Reimbursement Claims and Medical Chart Abstraction. Pragmatic and Observational Research 12, pages 49-63.
Read now
Read now
Felicia Forma, Eleena Koep, John White, Angela Belland, Heidi Waters & Carolyn Martin. (2021) Impact of treatment-related discussions on healthcare resource use and costs among patients with severe mental illness. Current Medical Research and Opinion 37:10, pages 1799-1809.
Read now
Read now
Alejandra Caqueo-Urízar, Alfonso Urzúa, Patricio Mena-Chamorro, Guillaume Fond & Laurent Boyer. (2020) Adherence to Antipsychotic Medication and Quality of Life in Latin-American Patients Diagnosed with Schizophrenia. Patient Preference and Adherence 14, pages 1595-1604.
Read now
Read now
Rosaria Di Lorenzo, Daniela Perrone, Anushree Montorsi, Jessica Balducci, Sergio Rovesti & Paola Ferri. (2020) Attitude Towards Drug Therapy in a Community Mental Health Center Evaluated by the Drug Attitude Inventory. Patient Preference and Adherence 14, pages 995-1010.
Read now
Read now
Clifton Blackwood, Panna Sanga, Isaac Nuamah, Alexander Keenan, Arun Singh, Maju Mathews & Srihari Gopal. (2020) Patients’ Preference for Long-Acting Injectable versus Oral Antipsychotics in Schizophrenia: Results from the Patient-Reported Medication Preference Questionnaire. Patient Preference and Adherence 14, pages 1093-1102.
Read now
Read now
Carlos De las Cuevas & Jose de Leon. (2020) Self-Report for Measuring and Predicting Medication Adherence: Experts’ Experience in Predicting Adherence in Stable Psychiatric Outpatients and in Pharmacokinetics. Patient Preference and Adherence 14, pages 1823-1842.
Read now
Read now
Yoshiteru Takekita, Sachie Inoue, Kenji Baba & Tadashi Nosaka. (2020) Rehospitalization Risk of Receptor-Affinity Profile in Antipsychotic Drug Treatment: A Propensity Score Matching Analysis Using a Japanese Employment-Based Health Insurance Database. Neuropsychiatric Disease and Treatment 16, pages 2871-2879.
Read now
Read now
Irma M Puspitasari, Rano K Sinuraya, Cherry Rahayu, Witriani Witriani, Uzlifatul Zannah, Auliani Hafifah, Ajeng R Ningtyas & Hilda Vildayanti. (2020) Medication Profile and Treatment Cost Estimation Among Outpatients with Schizophrenia, Bipolar Disorder, Depression, and Anxiety Disorders in Indonesia. Neuropsychiatric Disease and Treatment 16, pages 815-828.
Read now
Read now
Felicia Forma, Teresa Green, Seung Kim & Christie Teigland. (2020) Antipsychotic Medication Adherence and Healthcare Services Utilization in Two Cohorts of Patients with Serious Mental Illness. ClinicoEconomics and Outcomes Research 12, pages 123-132.
Read now
Read now
Wen Ling Hsieh, Shih Kai Lee, Wai Tong Chien, Wen I Liu, Chien Yu Lai & Chieh Yu Liu. (2019) Mediating Effect Of The Motivation For Medication Use On Disease Management And Medication Adherence Among Community-Dwelling Patients With Schizophrenia. Patient Preference and Adherence 13, pages 1877-1887.
Read now
Read now
Xue Song, Antoine C. El Khoury, Matthew Brouillette, David Smith & Kruti Joshi. (2019) Treatment discontinuation of long-acting injectables or oral atypical antipsychotics among Medicaid recipients with schizophrenia. Journal of Medical Economics 22:11, pages 1105-1112.
Read now
Read now
Laysha Ostrow, Bevin Croft, Anne Weaver & Sarah Naeger. (2019) An exploratory analysis of the role of social supports in psychiatric medication discontinuation: results related to family involvement. Psychosis 11:3, pages 212-222.
Read now
Read now
Jennifer Munday, Mallik Greene, Eunice Chang, Ann Hartry, Tingjian Yan & Michael S. Broder. (2019) Early initiation of long-acting injectable antipsychotic treatment is associated with lower hospitalization rates and healthcare costs in patients with schizophrenia: real-world evidence from US claims data. Current Medical Research and Opinion 35:7, pages 1231-1239.
Read now
Read now
Daisy Ng-Mak, Jiat-Ling Poon, Laurie Roberts, Leah Kleinman, Dennis A Revicki & Krithika Rajagopalan. (2018) Patient preferences for important attributes of bipolar depression treatments: a discrete choice experiment. Patient Preference and Adherence 12, pages 35-44.
Read now
Read now
Mallik Greene, Luciano Paladini, Teresa Lemmer, Alexandra Piedade, Maelys Touya & Otavio Clark. (2018) Systematic literature review on patterns of pharmacological treatment and adherence among patients with bipolar disorder type I in the USA. Neuropsychiatric Disease and Treatment 14, pages 1545-1559.
Read now
Read now
Mallik Greene, Tingjian Yan, Eunice Chang, Ann Hartry, Maëlys Touya & Michael S. Broder. (2018) Medication adherence and discontinuation of long-acting injectable versus oral antipsychotics in patients with schizophrenia or bipolar disorder. Journal of Medical Economics 21:2, pages 127-134.
Read now
Read now
Alejandra Caqueo-Urízar, Alfonso Urzúa, Guillaume Fond & Laurent Boyer. (2017) Medication nonadherence among South American patients with schizophrenia. Patient Preference and Adherence 11, pages 1737-1744.
Read now
Read now
Articles from other publishers (139)
Sylvia Martin. (2023) Why using “consciousness” in psychotherapy? Insight, metacognition and self-consciousness. New Ideas in Psychology 70, pages 101015.
Crossref
Crossref
Katharina Müller, Florian Schuster, Silvia Krumm, Stefan Leucht, Spyridon Siafis, Stephan Heres, Peter Brieger & Johannes Hamann. (2023) Informing the development of a decision aid: Expectations and wishes from service users and psychiatrists towards a decision aid for antipsychotics in the inpatient setting. Health Expectations 26:3, pages 1327-1338.
Crossref
Crossref
Parthasarathy Ramamurthy, Arya Jayasree, Susan Solomon, Vishnu V. Rudravaram, Vikas Menon & Pradeep Thilakan. (2023) Medication nonadherence and its associated factors in psychiatric patients in India: A systematic review and meta-analysis. Indian Journal of Psychiatry 65:5, pages 506-525.
Crossref
Crossref
Julia Spaton Goppers, Ellenor Mittendorfer-Rutz, Alexis E. Cullen, Christopher Jamil de Montgomery, Antti Tanskanen, Marie Norredam & Heidi Taipale. (2023) Antipsychotic treatment patterns in refugees and their Swedish-born peers with first-episode non-affective psychosis: findings from the REMAIN study. BJPsych Open 9:3.
Crossref
Crossref
Sony Subedi, Ni Gusti Ayu Nanditha, Hiwot M Tafessu, Hasan Nathani, Martin St-Jean, Julius Elefante, Thomas L Patterson, William G Honer, Julio S G Montaner & Viviane D Lima. (2023) Healthcare utilisation and costs associated with adherence to antipsychotics among people living with HIV/AIDS and schizophrenia: a population-based cohort study in British Columbia, Canada. BMJ Open 13:4, pages e070680.
Crossref
Crossref
Maia Asher, David Roe & Ilanit Hasson-Ohayon. (2023) Attitudes toward and patterns of medication use among people with serious mental illness: There’s more than meets the eye. Frontiers in Psychiatry 14.
Crossref
Crossref
Venla Lehti, Heidi Taipale, Mika Gissler, Antti Tanskanen, Martta Elonheimo, Jari Tiihonen & Jaana Suvisaari. (2021) Continuity of antipsychotic medication use among migrant and Finnish-born populations with a psychotic disorder: a register-based study. Psychological Medicine 53:3, pages 833-843.
Crossref
Crossref
Ana M. Sánchez-Torres, Silvia Amoretti, Mónica Enguita-Germán, Gisela Mezquida, Lucía Moreno-Izco, Rocío Panadero-Gómez, Lide Rementería, Alba Toll, Roberto Rodriguez-Jimenez, Alexandra Roldán, Edith Pomarol-Clotet, Ángela Ibáñez, Judith Usall, Fernando Contreras, Eduard Vieta, Jose M. López-Ilundain, Jessica Merchán-Naranjo, Ana González-Pinto, Esther Berrocoso, Miguel Bernardo, Manuel J. Cuesta, María Florencia Forte, Jairo M. González-Díaz, Mara Parellada, Hayford Abrokwa, María Sans Segura, Judit Selma González, Iñaki Zorrilla, Itxaso González-Ortega, Teresa Legido, Anna Mané, Luis Sanchez-Pastor, David Rentero, Salvador Sarró, Maria Ángeles García-León, Anna Butjosa, Marta Pardo, Amalia Zarzuela, María Ribeiro, Jerónimo Saiz-Ruiz, Leticia León-Quismondo, Miguel Hernández, Concepción de la Cámara, Miguel Gutiérrez-Fraile & Leticia González-Blanco. (2023) Relapse, cognitive reserve, and their relationship with cognition in first episode schizophrenia: a 3-year follow-up study. European Neuropsychopharmacology 67, pages 53-65.
Crossref
Crossref
Dan Thorpe, Jörg Strobel & Niranjan Bidargaddi. (2023) Examining clinician choice to follow-up (or not) on automated notifications of medication non-adherence by clinical decision support systems. BMC Medical Informatics and Decision Making 23:1.
Crossref
Crossref
Anna Maria Auxilia, Massimiliano Buoli, Alice Caldiroli, Greta Silvia Carnevali, Agnese Tringali, Roberto Nava, Massimo Clerici & Enrico Capuzzi. (2023) High Rate of Discontinuation during Long-Acting Injectable Antipsychotic Treatment in Patients with Psychotic Disorders. Biomedicines 11:2, pages 314.
Crossref
Crossref
Nelson Raluthaga, Hilda N. Shilubane & Mygirl Pearl Lowane. (2023) Relapse among MHCUs after a Short-Term Admission in an Acute Psychiatric Unit: Primary Caregivers’ Perspective. International Journal of Environmental Research and Public Health 20:2, pages 1384.
Crossref
Crossref
Núria Riera-Molist, Bruna Riera-Morera, Pere Roura-Poch, Josep Manel Santos-López & Quintí Foguet-Boreu. (2023) A Brief Psychoeducation Intervention to Prevent Rehospitalization in Severe Mental Disorder Inpatients. Journal of Nervous & Mental Disease 211:1, pages 40-45.
Crossref
Crossref
Steffen Moritz, Eva Carolin Krieger, Francesca Bohn, Julia Elmers & Ruth VeckenstedtSteffen Moritz, Eva Carolin Krieger, Francesca Bohn, Julia Elmers & Ruth Veckenstedt. 2023. MKT+. MKT+
9
57
.
Steffen Moritz, Eva Carolin Krieger, Francesca Bohn, Julia Elmers & Ruth VeckenstedtSteffen Moritz, Eva Carolin Krieger, Francesca Bohn, Julia Elmers & Ruth Veckenstedt. 2023. MKT+. MKT+
1
7
.
Chantele Mitchell-Miland, Sharon McCarthy & Matthew Chinman. (2022) Peer specialists deliver cognitive behavioral social skills training compared to social skills training and treatment as usual to veterans with serious mental illness: study protocol for a randomized controlled trial. Trials 23:1.
Crossref
Crossref
Sara S McMillan, Sarira El-Den, Claire L O’Reilly, Helena Roennfeldt, Theo Theodorus, Justin Chapman, Kylie Bailey, Keith Crump, Jack C Collins, Ricki Ng, Victoria Stewart & Amanda J Wheeler. (2022) A training programme for community pharmacists to support people living with severe and persistent mental illness: Intervention mapping in the context of a pandemic. Health Education Journal 81:8, pages 964-981.
Crossref
Crossref
Ondine Adam, Martin Blay, Andre R Brunoni, Hsin-An Chang, July S Gomes, Daniel C Javitt, Do-Un Jung, Joshua T Kantrowitz, Sanne Koops, Jean-Pierre Lindenmayer, Ulrich Palm, Robert C Smith, Iris E Sommer, Leandro do Costa Lane Valiengo, Thomas W Weickert, Jérôme Brunelin & Marine Mondino. (2022) Efficacy of Transcranial Direct Current Stimulation to Improve Insight in Patients With Schizophrenia: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Schizophrenia Bulletin 48:6, pages 1284-1294.
Crossref
Crossref
Simehlani Nyanyiwa, Kath Peters & Gillian Murphy. (2022) A scoping review: Treatment attitudes and adherence for adults with schizophrenia. Journal of Clinical Nursing 31:21-22, pages 3060-3075.
Crossref
Crossref
Andrea Aguglia, Laura Fusar-Poli, Antimo Natale, Andrea Amerio, Irene Espa, Veronica Villa, Giovanni Martinotti, Giuseppe Carrà, Francesco Bartoli, Armando D’Agostino, Gianluca Serafini, Mario Amore, Eugenio Aguglia, Giovanni Ostuzzi & Corrado Barbui. (2022) Factors Associated with Medication Adherence to Long-Acting
Injectable Antipsychotics: Results from the STAR Network Depot
Study. Pharmacopsychiatry 55:06, pages 281-289.
Crossref
Crossref
Waseem Sultan, Anup Mathew, Matthew R. D. Brown, Juan F. Gálvez-Flórez & Guillermo Moreno-Sanz. (2022) Cannabis-Based Medicinal Products in the Management of Emotionally Unstable Personality Disorder (EUPD): A Narrative Review and Case Series. Brain Sciences 12:11, pages 1467.
Crossref
Crossref
Sarah L. Starks, Erin L. Kelly, Enrico G. Castillo, Marcia L. Meldrum, Philippe Bourgois & Joel T. Braslow. (2020) Client Outreach in Los Angeles County’s Assisted Outpatient Treatment Program: Strategies and Barriers to Engagement. Research on Social Work Practice 32:7, pages 839-854.
Crossref
Crossref
Emily SimonAlyssa M. EdwardsMartha SajatovicNisha JainJessica L. MontoyaJennifer B. Levin. (2022) Systematic Literature Review of Text Messaging Interventions to Promote Medication Adherence Among People With Serious Mental Illness. Psychiatric Services 73:10, pages 1153-1164.
Crossref
Crossref
Shreedevi I. Balikai, Sreevani Rentala, Irasangappa Basavaraj Mudakavi & Raghavendra Bheemappa Nayak. (2022) Impact of nurse‐led medication adherence therapy on bipolar affective disorder: A randomized controlled trial. Perspectives in Psychiatric Care 58:4, pages 2676-2686.
Crossref
Crossref
Jill Bjarke, Helga Nødland Gjerde, Hugo Arild Jørgensen, Rune Andreas Kroken, Else-Marie Løberg & Erik Johnsen. (2022) Akathisia and atypical antipsychotics: relation to suicidality, agitation and depression in a clinical trial. Acta Neuropsychiatrica 34:5, pages 282-288.
Crossref
Crossref
Stefan Siebert, Karolina Leopold, Johanna Baumgardt, Laura-Sophie von Hardenberg, Eva Burkhardt & Andreas Bechdolf. (2022) Specialized inpatient treatment for young people with early psychosis: acute-treatment and 12-month results. European Archives of Psychiatry and Clinical Neuroscience 272:7, pages 1-14.
Crossref
Crossref
Aoife Carolan, Dolores Keating, Stephen McWilliams, Caroline Hynes, Mary O’Neill, Fiona Boland, Sharon Holland, Judith Strawbridge & Cristín Ryan. (2022) The development and validation of a medicines optimisation tool to protect the physical health of people with severe mental illness (OPTIMISE). BMC Psychiatry 22:1.
Crossref
Crossref
Akitoyo Hishimoto, Norio Yasui-Furukori, Daisuke Sekine, Miyuki Matsukawa & Sakiko Yamada. (2022) Treatment Discontinuation Among Patients with Schizophrenia Treated with Brexpiprazole and Other Oral Atypical Antipsychotics in Japan: A Retrospective Observational Study. Advances in Therapy 39:9, pages 4299-4314.
Crossref
Crossref
Giulia M. Giordano, Francesco Brando, Pasquale Pezzella, Maria De Angelis, Armida Mucci & Silvana Galderisi. (2022) Factors influencing the outcome of integrated therapy approach in schizophrenia: A narrative review of the literature. Frontiers in Psychiatry 13.
Crossref
Crossref
Olena Litvinova, Elisabeth Klager, Nikolay T. Tzvetkov, Oliver Kimberger, Maria Kletecka-Pulker, Harald Willschke & Atanas G. Atanasov. (2022) Digital Pills with Ingestible Sensors: Patent Landscape Analysis. Pharmaceuticals 15:8, pages 1025.
Crossref
Crossref
Retina Rimal, Joanne Lin, Amy Hai Yan Chan, Timothy F. Chen, Janie Sheridan & Frederick Sundram. (2022) A national study of the mental health literacy of community pharmacists. Research in Social and Administrative Pharmacy 18:8, pages 3303-3311.
Crossref
Crossref
Nathan Hodson, Madiha Majid, Ivo Vlaev & Swaran Preet Singh. (2022) Can incentives improve antipsychotic adherence in major mental illness? A mixed-methods systematic review. BMJ Open 12:6, pages e059526.
Crossref
Crossref
Chizimuzo T.C. Okoli, Amani Kappi, Tianyi Wang, Andrew Makowski & Andrew T. Cooley. (2021) The effect of long‐acting injectable antipsychotic medications compared with oral antipsychotic medications among people with schizophrenia: A systematic review and meta‐analysis. International Journal of Mental Health Nursing 31:3, pages 469-535.
Crossref
Crossref
Nina Vadiei, Jasim El-Ali, Joss Delaune, Cecilia Wild & Yi-Shao Liu. (2022) Patterns and predictors of oral antipsychotic prescribing in adult patients with schizophrenia. Exploratory Research in Clinical and Social Pharmacy 6, pages 100148.
Crossref
Crossref
Molly Patapoff, Marina Ramsey, Madison Titone, Christopher N. Kaufmann, Atul Malhotra, Sonia Ancoli-Israel, David Wing, Ellen Lee & Lisa T. Eyler. (2022) Temporal relationships of ecological momentary mood and actigraphy-based sleep measures in bipolar disorder. Journal of Psychiatric Research 150, pages 257-263.
Crossref
Crossref
Priyanthi B. Gjerde, Synne W. Steen, Trude S. J. Vedal, Nils Eiel Steen, Elina J. Reponen, Ole A. Andreassen, Vidar M. Steen & Ingrid Melle. (2022) Lifetime Cannabis Use Is Not Associated With Negative Beliefs About Medication in Patients With First Treatment Psychosis. Frontiers in Psychiatry 13.
Crossref
Crossref
Yao-Yu Lin, Wen-Jiuan Yen, Wen-Li Hou, Wei-Chou Liao & Mei-Ling Lin. (2022) Mental Health Nurses’ Tacit Knowledge of Strategies for Improving Medication Adherence for Schizophrenia: A Qualitative Study. Healthcare 10:3, pages 492.
Crossref
Crossref
Raakhi Tripathi, Sharmila JalgaonkarSnehalata GajbhiyeNishtha KhatriMohsin SayyedShubhangi Parkar. (2021) A Cross-Sectional, Questionnaire-Based Study on Drug Treatment Awareness in Schizophrenia Patients and Caregivers: An Unexplored Avenue. Indian Journal of Psychological Medicine 44:2, pages 137-144.
Crossref
Crossref
Massimo Moscarelli, Jung-Yun Min, Alex Kopelowicz, Oscar Chavez, Lizzette Gómez-de-Regil, Luis Salvador-Carulla, María Montes Gamez, Regina Vila-Badía, Cristina Romero-Lopez-Alberca & Anthony O. Ahmed. (2022) The “PRE” scale: The assessment of the elementary passively received experiences of schizophrenia. Schizophrenia Research 241, pages 218-220.
Crossref
Crossref
Alejandra Caqueo-Urízar, Patricio Mena-Chamorro, Alfonso Urzúa, Erika Peroza, Guillaume Fond & Laurent Boyer. (2022) Psychotic symptomatology and medication adherence in patients with schizophrenia: The mediating effect of awareness of mental disorder. Schizophrenia Research 241, pages 110-112.
Crossref
Crossref
Felicia Forma, Kevin Chiu, Jason Shafrin, Dusica Hadzi Boskovic & S Phani Veeranki. (2022) Are caregivers ready for digital? Caregiver preferences for health technology tools to monitor medication adherence among patients with serious mental illness. DIGITAL HEALTH 8, pages 205520762210844.
Crossref
Crossref
Jorge Luis Sotelo & Melanie Bilbul. 2022. Transplant Psychiatry. Transplant Psychiatry
167
176
.
Andrea Aguglia, Laura Fusar-Poli, Andrea Amerio, Valeria Placenti, Carmen Concerto, Giovanni Martinotti, Giuseppe Carrà, Francesco Bartoli, Armando D'Agostino, Gianluca Serafini, Mario Amore, Eugenio Aguglia, Giovanni Ostuzzi & Corrado Barbui. (2021) The Role of Attitudes Toward Medication and Treatment Adherence in the Clinical Response to LAIs: Findings From the STAR Network Depot Study. Frontiers in Psychiatry 12.
Crossref
Crossref
Merhawi Bahta, Azieb Ogbaghebriel, Mulugeta Russom, Eyasu H. Tesfamariam & Tzeggai Berhe. (2021) Impact of adverse reactions to first-generation antipsychotics on treatment adherence in outpatients with schizophrenia: a cross-sectional study. Annals of General Psychiatry 20:1.
Crossref
Crossref
Erica L. Stockbridge, Nathaniel J. Webb, Eleena Dhakal, Manasa Garg, Abiah D. Loethen, Thaddeus L. Miller & Karabi Nandy. (2021) Antipsychotic medication adherence and preventive diabetes screening in Medicaid enrollees with serious mental illness: an analysis of real-world administrative data. BMC Health Services Research 21:1.
Crossref
Crossref
Jesper Østrup Rasmussen, Poul Jennum, Kristian Linnet, Birte Y. Glenthøj & Lone Baandrup. (2021) Cannabidiol versus risperidone for treatment of recent-onset psychosis with comorbid cannabis use: study protocol for a randomized controlled clinical trial. BMC Psychiatry 21:1.
Crossref
Crossref
Frank Röhricht, Raguraman Padmanabhan, Paul Binfield, Deepa Mavji & Sally Barlow. (2021) Simple Mobile technology health management tool for people with severe mental illness: a randomised controlled feasibility trial. BMC Psychiatry 21:1.
Crossref
Crossref
David RoeNev JonesIlanit Hasson-OhayonYaara Zisman-Ilani. (2021) Conceptualization and Study of Antipsychotic Medication Use: From Adherence to Patterns of Use. Psychiatric Services 72:12, pages 1464-1466.
Crossref
Crossref
Ana Catalan, Lorena García, Sergio Sanchez‐Alonso, Patxi Gil, Marina Díaz‐Marsá, José Manuel Olivares, Tania Rivera‐Baltanás, Jorge Pérez‐Martín, Miguel Ángel González Torres, Santiago Ovejero, Meritxell Tost, Daniel Bergé, Alfonso Rodríguez & Javier Labad. (2020) Early intervention services, patterns of prescription and rates of discontinuation of antipsychotic treatment in first‐episode psychosis. Early Intervention in Psychiatry 15:6, pages 1584-1594.
Crossref
Crossref
Sun Lee & Shaina Schwartz. (2021) Adherence and persistence to long-acting injectable dopamine receptor blocking agent therapy in the United States: A systematic review and meta-analysis of cohort studies. Psychiatry Research 306, pages 114277.
Crossref
Crossref
Miquel Serra‐Burriel, Isabel Hurtado, Gabriel Sanfélix‐Gimeno, Aníbal García‐Sempere & Salvador Peiró. (2021) Cost‐Sharing Increase, Medication Adherence, and Hospitalizations in Schizophrenia Patients: A Natural Experiment. Clinical Pharmacology & Therapeutics 110:6, pages 1490-1497.
Crossref
Crossref
Claudio Brasso, Marta Cisotto, Camilla Ghirardini, Filippo Pennazio, Vincenzo Villari & Paola Rocca. (2021) Accuracy of self-reported adherence and therapeutic drug monitoring in a psychiatric emergency ward. Psychiatry Research 305, pages 114214.
Crossref
Crossref
John M. Kane, Joseph P. McEvoy, Christoph U. Correll & Pierre-Michel Llorca. (2021) Controversies Surrounding the Use of Long-Acting Injectable Antipsychotic Medications for the Treatment of Patients with Schizophrenia. CNS Drugs 35:11, pages 1189-1205.
Crossref
Crossref
Atefeh Mohammadjafari, Maryam Tabatabaee, Vandad Sharifi, Fattaneh Abdi Masouleh & Farid Abolhassani. (2021) Factors Associated with Adherence to Follow-up Among Patients with Depressive Disorders in a Collaborative Care Program in Iran. Iranian Journal of Psychiatry and Behavioral Sciences 15:4.
Crossref
Crossref
Lihle Mgweba-Bewana, Jennifer M. Belus, Jonathan Ipser, Jessica F. Magidson & John A. Joska. (2021) Examining the association of alcohol use and psychotropic medication adherence among women with severe mental illness in South Africa. Psychiatry Research 304, pages 114127.
Crossref
Crossref
John Lauriello, Peter J. Weiden, Carole D. Gleeson, Ankit Shah, Luke Boulanger, Krutika Jariwala-Parikh, Elizabeth Hedgeman & Amy K. O’Sullivan. (2021) Real-World Outcomes and Costs Following 6 Months of Treatment with the Long-Acting Injectable (LAI) Aripiprazole Lauroxil for the Treatment of Schizophrenia. CNS Drugs 35:10, pages 1123-1135.
Crossref
Crossref
Adam Jameson, Beth Fylan, Greg C. Bristow, Gurdeep S. Sagoo, Caroline Dalton, Alastair Cardno, Jaspreet Sohal & Samantha L. McLean. (2021) What Are the Barriers and Enablers to the Implementation of Pharmacogenetic Testing in Mental Health Care Settings?. Frontiers in Genetics 12.
Crossref
Crossref
Ita Fitzgerald, Sarah O'Dwyer, Margaret Brooks, Laura Sahm, Erin Crowley & Ciara Ní Dhubhlaing. (2021) Worth the Weight? Olanzapine Prescribing in Schizophrenia. A Review of Weight Gain and Other Cardiometabolic Side Effects of Olanzapine. Frontiers in Psychiatry 12.
Crossref
Crossref
Madeline Lim, Ziqiang Li, Huiting Xie, Bhing Leet Tan & Jimmy Lee. (2021) The Effect of Therapeutic Alliance on Attitudes Toward Psychiatric Medications in Schizophrenia. Journal of Clinical Psychopharmacology 41:5, pages 551-560.
Crossref
Crossref
Hiroyoshi Takeuchi, Stefan Leucht, John M Kane, Ofer Agid & Gary Remington. (2021) Antipsychotic Medications: Enhancing Use to Improve Outcomes. Schizophrenia Bulletin 47:5, pages 1201-1204.
Crossref
Crossref
Corinne Schaub, Catherine Bigoni, Quentin Baumeler, Mohamed Faouzi & Kétia Alexandre. (2021) The influence of psychosocial factors on the intention to incorporate complementary and integrative medicine into psychiatric clinical practices. Complementary Therapies in Clinical Practice 44, pages 101413.
Crossref
Crossref
Sophie Hirsch, Nancy Thilo, Tilman Steinert & Erich Flammer. (2021) Patients’ perception of coercion with respect to antipsychotic treatment of psychotic disorders and its predictors. Social Psychiatry and Psychiatric Epidemiology 56:8, pages 1381-1388.
Crossref
Crossref
Rim Taleb, Nayla Kassab, Asmaa Kebbe & Nour Kreidieh. (2020) Mental health literacy of the Lebanese population (MHeLLP): a cross-sectional study. Journal of Public Mental Health 20:2, pages 132-144.
Crossref
Crossref
Karan Kverno & Ilya Rozenberg. (2021) Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia: Practical Considerations. Journal of Psychosocial Nursing and Mental Health Services 59:7, pages 7-12.
Crossref
Crossref
Abdelrahim Alqudah, Ahmad Al‐Smadi, Muna Oqal, Esam Y. Qnais, Mohammed Wedyan, Majd Abu Gneam, Roaa Alnajjar, Manar Alajarmeh, Elaf Yousef & Omar Gammoh. (2021) About anxiety levels and anti‐anxiety drugs among quarantined undergraduate Jordanian students during COVID‐19 pandemic. International Journal of Clinical Practice 75:7.
Crossref
Crossref
Dulcinea Vega, Francisco J. Acosta & Pedro Saavedra. (2021) Nonadherence after hospital discharge in patients with schizophrenia or schizoaffective disorder: A six-month naturalistic follow-up study. Comprehensive Psychiatry 108, pages 152240.
Crossref
Crossref
Wei Yu, Jie Tong, Xirong Sun, Fazhan Chen, Jie Zhang, Yu Pei, Tingting Zhang, Jiechun Zhang & Binggen Zhu. (2021) Analysis of Medication Adherence and Its Influencing Factors in Patients with Schizophrenia in the Chinese Institutional Environment. International Journal of Environmental Research and Public Health 18:9, pages 4746.
Crossref
Crossref
Jeffrey M. Cochran, Zahra Heidary & Jonathan Knights. (2021) Characterization of activity behavior using a digital medicine system and comparison to medication ingestion in patients with serious mental illness. npj Digital Medicine 4:1.
Crossref
Crossref
Emily Simon, Jennifer B. Levin, Jessie Mbwambo, Carol Blixen, Isaac Lema, Michelle Aebi, Godwin Njiro, Kristin Cassidy, Sylvia Kaaya & Martha Sajatovic. (2021) Alcohol use in Tanzanians with chronic psychotic disorders and poor medication adherence. South African Journal of Psychiatry 27.
Crossref
Crossref
Jebril M. Benelmokhtar, Bonginkosi Chiliza, Lebogang Phahladira, Robin Emsley & Laila Asmal. (2021) Factors associated with dropout at 2 years post-initiation of treatment in the first episode of schizophrenia. South African Journal of Psychiatry 27.
Crossref
Crossref
Zahra Heidary, Jeffrey M Cochran, Timothy Peters-Strickland & Jonathan Knights. (2021) A Rest Quality Metric Using a Cluster-Based Analysis of Accelerometer Data and Correlation With Digital Medicine Ingestion Data: Algorithm Development. JMIR Formative Research 5:3, pages e17993.
Crossref
Crossref
Yusuke Iwata, Yu Aruga, Masataka Ohtsuki, Masahiro Inoue, Kazuyuki Yasuda, Takashi Hirata, Takuji Uemura & Takefumi Suzuki. (2021) Successful Introduction of Paliperidone Palmitate for Pregnant Woman With Schizophrenia. Journal of Clinical Psychopharmacology 41:2, pages 210-212.
Crossref
Crossref
Cynthia L. Bianco, Amanda L. Myers, Stephen Smagula & Karen L. Fortuna. (2021) Can Smartphone Apps Assist People with Serious Mental Illness in Taking Medications as Prescribed?. Sleep Medicine Clinics 16:1, pages 213-222.
Crossref
Crossref
Michelle O'Reilly, Nikki Kiyimba & Alison Drewett. (2020) Mixing qualitative methods versus methodologies: A critical reflection on communication and power in inpatient care. Counselling and Psychotherapy Research 21:1, pages 66-76.
Crossref
Crossref
Tong Zhu. (2021) Challenges of Psychiatry Drug Development and the Role of Human Pharmacology Models in Early Development—A Drug Developer's Perspective. Frontiers in Psychiatry 11.
Crossref
Crossref
Chuan-Chia Chang, Yu-Chen Kao, Che-Yi Chao, Nian-Sheng Tzeng & Hsin-An Chang. (2021) The Effects of Bi-Anodal tDCS Over the Prefrontal Cortex Regions With Extracephalic Reference Placement on Insight Levels and Cardio-Respiratory and Autonomic Functions in Schizophrenia Patients and Exploratory Biomarker Analyses for Treatment Response. International Journal of Neuropsychopharmacology 24:1, pages 40-53.
Crossref
Crossref
J. Leijala, O. Kampman, J. Suvisaari & S. Eskelinen. (2021) Daily functioning and symptom factors contributing to attitudes toward antipsychotic treatment and treatment adherence in outpatients with schizophrenia spectrum disorders. BMC Psychiatry 21:1.
Crossref
Crossref
Laurent Béchard, Olivier Corbeil, Esthel Malenfant, Catherine Lehoux, Emmanuel Stip, Marc-André Roy & Marie-France Demers. (2021) Une approche de la psychopharmacologie des premiers épisodes psychotiques axée sur le rétablissementPsychopharmacology of First Episode Psychosis: An Approach Based on Recovery. Santé mentale au Québec 46:2, pages 113.
Crossref
Crossref
Hemlata Ghatwal, Jaison Joseph & Purushottam Jangid. (2021) Effect of nurse-led screening linked brief psycho-education for improving adherence to antipsychotic medications among clients with mental illness: A quasi-experimental study. Journal of Mental Health and Human Behaviour 26:1, pages 28.
Crossref
Crossref
Anthony Kramer & Pamela Bjorklund. (2020) Implementation and evaluation of a psychoeducation program in an outpatient mental health center. Perspectives in Psychiatric Care 57:1, pages 219-224.
Crossref
Crossref
Paul McCrone, Iris Mosweu, Deokhee Yi, Tamatha Ruffell, Bethan Dalton & Til Wykes. (2021) Patient Preferences for Antipsychotic Drug Side Effects: A Discrete Choice Experiment. Schizophrenia Bulletin Open 2:1.
Crossref
Crossref
Sylvia Martin, Pierluigi Graziani & Jonathan Del-Monte. (2021) Insight's level in borderline personality disorder, questioning consciousness. Journal of Affective Disorders Reports 3, pages 100045.
Crossref
Crossref
Andrew M. Peterson. 2021. Handbook of Evidence-Based Prevention of Behavioral Disorders in Integrated Care. Handbook of Evidence-Based Prevention of Behavioral Disorders in Integrated Care
327
340
.
Leona Bessonova, Dawn I. Velligan, Peter J. Weiden, Amy K. O’Sullivan, Aaron Yarlas, Martha Bayliss, Nishtha Baranwal, Kaitlin Rychlec, Julia Carpenter-Conlin, Michael J. Doane & Martha Sajatovic. (2020) Antipsychotic treatment experiences of people with bipolar I disorder: patient perspectives from an online survey. BMC Psychiatry 20:1.
Crossref
Crossref
Daniel Schöttle, Wolfgang Janetzky, Daniel Luedecke, Elmar Beck, Christoph U. Correll & Klaus Wiedemann. (2020) The use of long-acting Aripiprazole in a multi-center, prospective, uncontrolled, open-label, cohort study in Germany: a report on global assessment of functioning and the WHO wellbeing index. BMC Psychiatry 20:1.
Crossref
Crossref
Dulcinea Vega, Francisco J Acosta & Pedro Saavedra. (2020) Testing the hypothesis of subtypes of nonadherence in schizophrenia and schizoaffective disorder: A prospective study. World Journal of Psychiatry 10:11, pages 260-271.
Crossref
Crossref
Vaios Peritogiannis, Afroditi Gogou & Maria Samakouri. (2020) Very long-term outcome of psychotic disorders. International Journal of Social Psychiatry 66:7, pages 633-641.
Crossref
Crossref
Giampaolo Perna, Francesco Cuniberti, Silvia Daccò, Massimiliano Grassi & Daniela Caldirola. (2020) ‘Precision’ or ‘personalized’ psychiatry: different terms – same content?. Fortschritte der Neurologie · Psychiatrie 88:12, pages 759-766.
Crossref
Crossref
Fareha Begum, Stanley Mutsatsa, Noreen Gul, Ben Thomas & Chris Flood. (2020) Antipsychotic medication side effects knowledge amongst registered mental health nurses in England: A national survey. Journal of Psychiatric and Mental Health Nursing 27:5, pages 521-532.
Crossref
Crossref
Chongmei Huang, Virginia Plummer, Yun Wang, Louisa Lam & Wendy Cross. (2020) I am the person who knows myself best: Perception on shared decision‐making among hospitalized people diagnosed with schizophrenia in China. International Journal of Mental Health Nursing 29:5, pages 846-855.
Crossref
Crossref
Nathan T.M. Huneke, Nic van der Wee, Matthew Garner & David S. Baldwin. (2020) Why we need more research into the placebo response in psychiatry. Psychological Medicine 50:14, pages 2317-2323.
Crossref
Crossref
Chin-Chao Ma, Yu-Chen Kao, Nian-Sheng Tzeng, Che-Yi Chao, Chuan-Chia Chang & Hsin-An Chang. (2020) A higher degree of insight impairment in stabilized schizophrenia patients is associated with reduced cardiac vagal tone as indexed by resting-state high-frequency heart rate variability. Asian Journal of Psychiatry 53, pages 102171.
Crossref
Crossref
Elisabetta Maffioletti, Paolo Valsecchi, Alessandra Minelli, Chiara Magri, Cristian Bonvicini, Stefano Barlati, Emilio Sacchetti, Antonio Vita & Massimo Gennarelli. (2020)
Association study between
HTR2A
rs6313 polymorphism and early response to risperidone and olanzapine in schizophrenia patients
. Drug Development Research 81:6, pages 754-761.
Crossref
Crossref
H. Takeuchi, C. Borlido, M. Sanches, C. Teo, L. Harber, O. Agid & G. Remington. (2020) Adherence to clozapine vs. other antipsychotics in schizophrenia. Acta Psychiatrica Scandinavica 142:2, pages 87-95.
Crossref
Crossref
Yu-Chen Kao, Nian-Sheng Tzeng, Che-Yi Chao, Chuan-Chia Chang & Hsin-An Chang. (2020) Modulation of self-appraisal of illness, medication adherence, life quality and autonomic functioning by transcranial direct current stimulation in schizophrenia patients. Clinical Neurophysiology 131:8, pages 1997-2007.
Crossref
Crossref
Krishanand R. Roopun, Andrew Tomita & Saeeda Paruk. (2020) Attitude and preferences towards oral and long-acting injectable antipsychotics in patients with psychosis in KwaZulu-Natal, South Africa. South African Journal of Psychiatry 26.
Crossref
Crossref
Amy Werremeyer, Elizabeth Skoy, William Burns & Amber Bach-Gorman. (2020) Photovoice as an intervention for college students living with mental illness: A pilot study. Mental Health Clinician 10:4, pages 237-243.
Crossref
Crossref
Elaina Charlotte Taylor, Mark O'Neill, Lyndsay D. Hughes, Peter Bennett & Rona Moss-Morris. (2020) Examining Adherence to Medication in Patients With Atrial Fibrillation. Journal of Cardiovascular Nursing 35:4, pages 337-346.
Crossref
Crossref
Mark Sulkowski, Annie F. Luetkemeyer, David L. Wyles, Claudia Martorell, Andrew Muir, Ilan Weisberg, Stuart C. Gordon, Richard McLain & Gregory Huhn. (2020) Impact of a digital medicine programme on hepatitis C treatment adherence and efficacy in adults at high risk for non-adherence. Alimentary Pharmacology & Therapeutics 51:12, pages 1384-1396.
Crossref
Crossref
Luis Gutiérrez-Rojas, José María Martínez-Ortega, Lucía Pérez-Costillas, Sara Jiménez-Fernández, María Dolores Carretero & Manuel Gurpegui. (2020) Illness Insight and Medication Adherence Among Patients With Bipolar Disorder. Journal of Nervous & Mental Disease 208:6, pages 481-487.
Crossref
Crossref
Hodaka Yaegashi, So Kirino, Gary Remington, Fuminari Misawa & Hiroyoshi Takeuchi. (2020) Adherence to Oral Antipsychotics Measured by Electronic Adherence Monitoring in Schizophrenia: A Systematic Review and Meta-analysis. CNS Drugs 34:6, pages 579-598.
Crossref
Crossref
José Miguel Meca García, Miguel Soto Ontoso, Eliana Gómez Padrón, María Rosa Sanchez-Waisen Hernández & Yaiza Rojas Vallejo. (2020) Estudio observacional sobre los efectos del palmitato de paliperidona inyectable mensual sobre la hospitalización y asistencia urgente. Psiquiatría Biológica 27:2, pages 43-46.
Crossref
Crossref
Julia Kim, Miracle Ozzoude, Shinichiro Nakajima, Parita Shah, Fernando Caravaggio, Yusuke Iwata, Vincenzo De Luca, Ariel Graff-Guerrero & Philip Gerretsen. (2020) Insight and medication adherence in schizophrenia: An analysis of the CATIE trial. Neuropharmacology 168, pages 107634.
Crossref
Crossref
Maxim Zavorotnyy, Frank Ehrlich & Igor Nenadic. (2020) Health‐related Internet use and treatment adherence: A transdiagnostic comparison of outpatients with major depressive disorder and schizophrenia. PsyCh Journal 9:2, pages 174-184.
Crossref
Crossref
Chalachew Kassaw, Elias Tesfaye, Shimelis Girma & Liyew Agenagnew. (2020) Perceived Patient Satisfaction and Associated Factors among Psychiatric Patients Who Attend Their Treatment at Outpatient Psychiatry Clinic, Jimma University Medical Center, Southwest Ethiopia, Jimma, 2019. Psychiatry Journal 2020, pages 1-10.
Crossref
Crossref
Jens Bohlken, Marcel Konrad & Karel Kostev. (2020) Adherence to neuroleptic treatment in psychiatric practices: A retrospective study of 55 practices with more than 5000 bipolar and schizophrenic patients in Germany. Psychiatry Research 284, pages 112758.
Crossref
Crossref
Virginia M. Conley, Sandra Daack-Hirsch, Katie Halbmaier & Lisa Shaw. (2019) Bringing Personalized Medicine to a PACT Program: A Quality Improvement Project. Journal of the American Psychiatric Nurses Association 26:1, pages 77-85.
Crossref
Crossref
Nidhi Chauhan, Subho Chakrabarti & Sandeep Grover. (2020) Attitudes to Medication—Treatment Among Patients and Caregivers. Journal of Clinical Psychopharmacology 40:1, pages 18-29.
Crossref
Crossref
Nakao Iwata, Jun Ishigooka, Won-Hyoung Kim, Bo-Hyun Yoon, Shih-Ku Lin, Ahmad Hatim Sulaiman, Rowena Cosca, Lina Wang, Yury Suchkov, Alexey Agarkov, Kei Watabe, Tomohito Matsui, Takayuki Sato, Yoshifumi Inoue, Teruhiko Higuchi, Christoph U. Correll & John M. Kane. (2020) Efficacy and safety of blonanserin transdermal patch in patients with schizophrenia: A 6-week randomized, double-blind, placebo-controlled, multicenter study. Schizophrenia Research 215, pages 408-415.
Crossref
Crossref
Vaios Peritogiannis, Aikaterini Grammeniati, Afroditi Gogou, Panagiota Gioti & Venetsanos Mavreas. (2019) Very Long-Term Outcome of Community-Dwelling Patients With Schizophrenia Spectrum Disorders in Rural Greece. Journal of Nervous & Mental Disease 207:12, pages 1012-1018.
Crossref
Crossref
Afzal Javed, Holger Arthur, Logos Curtis, Lars Hansen & Sofia Pappa. (2019) Practical Guidance on the Use of Lurasidone for the Treatment of Adults with Schizophrenia. Neurology and Therapy 8:2, pages 215-230.
Crossref
Crossref
Fumiko Kaneko & Hitoshi Okamura. (2019) Discrepancies between Self- and Clinical Staff Members’ Perception of Cognitive Functioning among Patients with Schizophrenia Undergoing Long-Term Hospitalization. Occupational Therapy International 2019, pages 1-10.
Crossref
Crossref
Aoife Carolan, Dolores Keating, Judith Strawbridge & Cristin Ryan. (2019) Optimising prescribing for patients with severe mental illness: the need for criteria. Evidence Based Mental Health 22:4, pages 139-141.
Crossref
Crossref
Konstantin Mechler & Alexander Häge. (2019) “Drugs Don’t Work in Patients Who Don’t Take Them”. Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie 47:6, pages 528-534.
Crossref
Crossref
Sam Reid & Sagnik Bhattacharyya. (2019) Antipsychotic treatment failure in patients with psychosis and co-morbid cannabis use: A systematic review. Psychiatry Research 280, pages 112523.
Crossref
Crossref
Sylvia Martin, Jonathan Del-Monte & Pierluigi Graziani. (2019) Impulsivity issues in borderline personality disorder and it's links with insight: the role of urgency. Heliyon 5:10, pages e02564.
Crossref
Crossref
Subho Chakrabarti. (2019) Treatment Attitudes and Adherence Among Patients with Bipolar Disorder: A Systematic Review of Quantitative and Qualitative Studies. Harvard Review of Psychiatry 27:5, pages 290-302.
Crossref
Crossref
Shunya Kurokawa, Taishiro Kishimoto, Kuan-Pin Su, Jane Pei-Chen Chang, Hui-Chih Chang, Xin Yu, Nuno Rodrigues-Silva, Jimmi Nielsen, Anish Unadkat, David Castle, Peter M. Haddad, Deyvis Rocha, Ary Gadelha, Styliani Kaliora, Georgios Petrides, Ofer Agid, Yuki Tazawa, Akihiro Takamiya, Toshiro Horigome & John M. Kane. (2019) Psychiatrists' perceptions of medication adherence among patients with schizophrenia: An international survey. Schizophrenia Research 211, pages 105-107.
Crossref
Crossref
Elizabeth S. Smith, Joshua E. Porterfield & Rangaramanujam M. Kannan. (2019) Leveraging the interplay of nanotechnology and neuroscience: Designing new avenues for treating central nervous system disorders. Advanced Drug Delivery Reviews 148, pages 181-203.
Crossref
Crossref
Ilene Corina, Marissa Abram & David Halperin. (2019) The Patient’s Role in Patient Safety. Obstetrics and Gynecology Clinics of North America 46:2, pages 215-225.
Crossref
Crossref
J.‐G. Daneault, A. Maraj, M. Lepage, A. Malla, N. Schmitz, S. N. Iyer, R. Joober & J. L. Shah. (2019) Medication adherence in first episode psychosis: the role of pre‐onset subthreshold symptoms. Acta Psychiatrica Scandinavica 139:4, pages 336-347.
Crossref
Crossref
Lebogang Phahladira, Laila Asmal, Sanja Kilian, Bonginkosi Chiliza, Frederika Scheffler, Hilmar K. Luckhoff, Stefan du Plessis & Robin Emsley. (2019) Changes in insight over the first 24 months of treatment in schizophrenia spectrum disorders. Schizophrenia Research 206, pages 394-399.
Crossref
Crossref
Jonathan Knights, Zahra Heidary, Timothy Peters-Strickland & Murali Ramanathan. (2019) Evaluating digital medicine ingestion data from seriously mentally ill patients with a Bayesian Hybrid Model. npj Digital Medicine 2:1.
Crossref
Crossref
Daniel Schöttle & Jürgen Gallinat. (2019) Neugestaltung einer Akutpsychiatrie – ein WerkstattberichtReorganization of acute psychiatry—a workshop report. Forensische Psychiatrie, Psychologie, Kriminologie 13:1, pages 13-21.
Crossref
Crossref
Emily J. Hauenstein, Rachael S. Clark & Elizabeth I. Merwin. (2018) Modeling Health Disparities and Outcomes in Disenfranchised Populations. Community Mental Health Journal 55:1, pages 9-23.
Crossref
Crossref
Jeroen Deenik, Diederik E. Tenback, Harold F. van Driel, Erwin C. P. M. Tak, Ingrid J. M. Hendriksen & Peter N. van Harten. (2018) Less Medication Use in Inpatients With Severe Mental Illness Receiving a Multidisciplinary Lifestyle Enhancing Treatment. The MULTI Study III. Frontiers in Psychiatry 9.
Crossref
Crossref
Daniel Schöttle, Wolfgang Janetzky, Daniel Luedecke, Elmar Beck, Christoph U. Correll & Klaus Wiedemann. (2018) Effectiveness of aripiprazole once-monthly in schizophrenia patients pretreated with oral aripiprazole: a 6-month, real-life non-interventional study. BMC Psychiatry 18:1.
Crossref
Crossref
I. García-Cabeza, C.M. Díaz-Caneja, M. Ovejero & E. de Portugal. (2018) Adherence, insight and disability in paranoid schizophrenia. Psychiatry Research 270, pages 274-280.
Crossref
Crossref
Jaana Suvisaari, Outi Mantere, Jaakko Keinänen, Teemu Mäntylä, Eva Rikandi, Maija Lindgren, Tuula Kieseppä & Tuukka T. Raij. (2018) Is It Possible to Predict the Future in First-Episode Psychosis?. Frontiers in Psychiatry 9.
Crossref
Crossref
Parita Shah, Yusuke Iwata, Eric Plitman, Eric E. Brown, Fernando Caravaggio, Julia Kim, Shinichiro Nakajima, Margaret Hahn, Gary Remington, Philip Gerretsen & Ariel Graff-Guerrero. (2018) The impact of delay in clozapine initiation on treatment outcomes in patients with treatment-resistant schizophrenia: A systematic review. Psychiatry Research 268, pages 114-122.
Crossref
Crossref
Tingjian Yan, Mallik Greene, Eunice Chang, Ann Hartry, Maëlys Touya & Michael S. Broder. (2018) Medication Adherence and Discontinuation of Aripiprazole Once-Monthly 400 mg (AOM 400) Versus Oral Antipsychotics in Patients with Schizophrenia or Bipolar I Disorder: A Real-World Study Using US Claims Data. Advances in Therapy 35:10, pages 1612-1625.
Crossref
Crossref
Martin Salzmann-Erikson & Marie Sjödin. (2018) A narrative meta-synthesis of how people with schizophrenia experience facilitators and barriers in using antipsychotic medication: Implications for healthcare professionals. International Journal of Nursing Studies 85, pages 7-18.
Crossref
Crossref
Cătălina Angela Crișan. 2018. Psychotic Disorders - An Update. Psychotic Disorders - An Update.
Ulla A. Botha, Marise Coetzee, Liezl Koen & Dana J.H. Niehaus. (2018) An Attempt to Stem the Tide: Exploring the Effect of a 90-Day Transitional Care Intervention on Readmissions to an Acute Male Psychiatric Unit in South Africa. Archives of Psychiatric Nursing 32:3, pages 384-389.
Crossref
Crossref
Sven Wasserthal, Christian Kloss, René Hurlemann & Johannes Schultz. (2018) N-Acetylcystein: neue Option zur frühen Bekämpfung von Schizophrenie. DNP - Der Neurologe & Psychiater 19:2, pages 28-34.
Crossref
Crossref
Redhouane Abdellaoui, Pierre Foulquié, Nathalie Texier, Carole Faviez, Anita Burgun & Stéphane Schück. (2018) Detection of Cases of Noncompliance to Drug Treatment in Patient Forum Posts: Topic Model Approach. Journal of Medical Internet Research 20:3, pages e85.
Crossref
Crossref
Tobias Feldhaus, Sebastian Falke, Lara von Gruchalla, Birgit Maisch, Christina Uhlmann, Eva Bock & Rebekka Lencer. (2018) The impact of self-stigmatization on medication attitude in schizophrenia patients. Psychiatry Research 261, pages 391-399.
Crossref
Crossref
Paul H. Lysaker, Michelle L. Pattison, Bethany L. Leonhardt, Scott Phelps & Jenifer L. Vohs. (2018) Insight in schizophrenia spectrum disorders: relationship with behavior, mood and perceived quality of life, underlying causes and emerging treatments. World Psychiatry 17:1, pages 12-23.
Crossref
Crossref
Anil S Modak. (2017) Point-of-care companion diagnostic tests for personalizing psychiatric medications: fulfilling an unmet clinical need. Journal of Breath Research 12:1, pages 017101.
Crossref
Crossref
A. Tinland, K. Zemmour, P. Auquier, M. Boucekine, V. Girard, S. Loubière, G. Fond & Laurent Boyer. (2017) Homeless women with schizophrenia reported lower adherence to their medication than men: results from the French Housing First experience. Social Psychiatry and Psychiatric Epidemiology 52:9, pages 1113-1122.
Crossref
Crossref